Endocrine therapy resistance: what we know and future directions

Endocrine resistance is a major hurdle in the treatment of estrogen receptor (ER)-positive breast cancer. When abnormally regulated, molecular signals responsible for cellular proliferation, as well as ER itself, allow for cellular evasion of ER-dependent treatments. Therefore, pharmacological treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Musheyev, David, Alayev, Anya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Exploration 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446423/
https://www.ncbi.nlm.nih.gov/pubmed/36071983
http://dx.doi.org/10.37349/etat.2022.00096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446423/
https://www.ncbi.nlm.nih.gov/pubmed/36071983
http://dx.doi.org/10.37349/etat.2022.00096

Ejemplares similares